Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
144 hedge funds and large institutions have $1.1B invested in Cantel Medical Corporation in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 56 reducing their positions, and 9 closing their positions.
144% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 9
15% more capital invested
Capital invested by funds: $962M → $1.1B (+$141M)
8% more funds holding
Funds holding: 133 → 144 (+11)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
16% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 56
43% less call options, than puts
Call options by funds: $556K | Put options by funds: $974K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
+$87M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$11.3M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$9.06M |
| 4 |
Morgan Stanley
New York
|
+$7.34M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$18.8M |
| 2 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$7.22M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$4.82M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$4.58M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$3.56M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
SG Americas Securities
New York
| – | -$196K | -6,161 | Closed |
|
|
RA
152
Rational Advisors
Huntington,
New York
| – | -$169K | -5,317 | Closed |
|
|
FQ
153
First Quadrant
Glendale,
California
| – | -$72K | -2,250 | Closed |
|
CMD Hedge Fund Activity: Q4 2013 in Review
144 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q4 2013, worth a combined $1.1B — up 15% from $962M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CMD positions and 9 closed out — a net gain of 13 holders — while 47 added to existing stakes and 56 trimmed.
The largest buyer was EARNEST Partners, opening a new position worth an estimated $87M. The largest seller was Boston Trust Walden, cutting an estimated $18.8M.
- 144 institutional investors held Cantel Medical Corporation (CMD) as of Q4 2013, up from 133 in Q3 2013.
- Funds reported $1.1B of Cantel Medical Corporation stock for Q4 2013, up 15% quarter-over-quarter.
- 22 funds opened new Cantel Medical Corporation positions in Q4 2013 and 9 closed out, a net change of +13 holders.
- The largest Cantel Medical Corporation buyer in Q4 2013 was EARNEST Partners, an estimated $87M added.
- The largest Cantel Medical Corporation seller in Q4 2013 was Boston Trust Walden, an estimated $18.8M sold.
Based on aggregated 13F filings for Q4 2013.